DAFTAR PUSTAKA

1.

Tessy A, Ardayo, Suwanto. Infeksi salauran kemih dalam Buku Ajar Ilmu
Penyakit Dalam. Jilid 3. Edisi 3. Jakarta : Balai Penerbit FKUI; 2001. h .369

2.

Achmad IA, dkk. Guidelines Penatalaksanaan Infeksi Saluran Kemih (ISK)

dan Genetalia Pria. Jakarta.2007.hal.1

3.

Ginting Yosia. Antimicrobial Usage of UTIs in Elderly in Abstracts Book 8th

JADE 2007. Jakarta : Divisi penyakit tropis dan Infeksi IPD-RSCM ; h.18

4.

Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: whats old,
whats new, and what works. World J Urol. 1999;17(6): 37282

5.

Sobel J D, Kaye D. Urinary tract infection in Mandell, douglas and Bennetts.

Principles and Practice of Infections Diseases. 6th ed. Philadelphia: Elsevier;
2005. p. 881-2

6.

Hooton, T. M. Fluoroquinolones and resistance in the treatment of

uncomplicated urinary tract infection. Int. J. Antimicrob. Agents.2003.
22:56572.

7.

Huang, E. S., and R. S. Stafford. National patterns in the treatment of urinary

tract infections in women by ambulatory care physicians. Arch. Intern. Med.
200. 162:4147.

8.

Naber, K. G. Survey on antibiotic usage in the treatment of urinary tract

infections. J. Antimicrob. Chemother. 2000. 46(Suppl. 1):4952.

9.

Shao HF, Wang WP, Zhang XW, Li ZD. Distribution and resistance trends of
pathogens from urinary tract infections and impact on management.
Zhonghua Nan Ke Xue. 2003;9(9):690692, 696.

10. Kahlmeter G. An international survey of the antimicrobial susceptibility of

pathogens from uncomplicated urinary tract infections: the ECO.SENS
Project. J Antimicrob Chemother. 2003;51(1):6976.
11. Iqbal J, Rahman M, Kabir MS, Rahman M. Increasing ciprofloxacin
resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jpn
J Med Sci Biol. 1997;50(6):241250.
12. Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D, Catal C, Ang-Kucuker
M,

Ang

O.

Relationship

Pola kepekaan ..., Firdaus N., FK UI., 2009

between
53

ciprofloxacin

resistance

and

Universitas Indonesia

54

extendedspectrum beta-lactamase production in Escherichia coli and

Klebsiella pneumoniae strains. ClinMicrobiol Infect. 2004;10(1):7275.
13. Hooper DC. Emerging Mechanism of Fluoroquinolone Resistance. Emerging
Infectious Disease. Vol. 7, No. 2, March-April 2001
14. Sukandar E. Infeksi saluran kemih pada pasien dewasa dalam Buku Ajar
Ilmu Penyakit Dalam. Jilid I. Edisi IV. Jakarta : Balai Penerbit FKUI; 2007.
h.553-7
15. Mims et al. Medical microbiology. 2nd ed. London: Mosby; 2005. p. 25-7,
411-9
16. Brooks GF, Butel JS, Morse SA. Jawetz, melnick, & adelbergs medical
microbiology. 23rd ed. New York:Lange medical books;2004. p. 15-31, 184-6
17. Boel T. infeksi Saluran Kemih. Diunduh dari USU digital library. 2004
18. Crumplin, G. C., M. Kenwright, and T. Hirst. Investigations into the
mechanisms of action of the antibacterial agent norfloxacin. J. Antimicrob.
Chemother. 1984. 13(Suppl. B):9-23.
19. Ryan K J, editor. Sherris medical microbiology. New York: Prentice-Hall
International Inc.; 1998
20. Setiabudi Rianto. Pengantar Antimikroba dalam Farmakologi dan Terapi.
Edisi 7. Jakarta: Gaya Baru; 2007. h. 596
21. Setiabudy R. Golongan kuinolon dan fluorokuinolon. Dalam Farmakologi
dan Terapi. Edisi 7. Jakarta: Gaya Baru; 2007. h. 718-719
22. Drago L, De Vecchi E, Mombelli B, Nicola L, Valli M, Gismondo MR.
Activity of levofloxacin and ciprofloxacin against urinary pathogens. J
Antimicrob Chemother. 2001;48(1):3745.
23. Kamberi M, Tsutsumi K, Kotegawa T, et al. Influences of urinary pH on
ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro
versus those of sparfloxacin. Antimicrob Agents Chemother. 1999;43(3):525
529.
24. King DE, Malone R, Lilley SH. New classification and update on the
quinolone antibiotics. Am Fam Physician. 2000;61(9):27412748.
25. Jacoby, G. A. Mechanisms of resistance to quinolones. Clin. Infect. Dis.
2005. 41(Suppl. 2):S120S126.

Pola kepekaan ..., Firdaus N., FK UI., 2009

Universitas Indonesia

55

26. Nordmann, P., and L. Poirel. Emergence of plasmid-mediated resistance to

quinolones in Enterobacteriaceae. J.Antimicrob. 2005.Chemother. 56: 463-9.
27. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H.
Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme:
a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med.
12:8388.
28. Samirah, dkk..Pola dan Sensitivitas Kuman di Penderita Infeksi Saluran
Kemih

dalam Indonesian Journal of Clinical Pathology and Medical

Laboratory, Vol. 12, No. 3, Juli 2006: 110-113

29. Navaneeth BV, Belwadi S, Suganthi N. Urinary pathogens resistance to
common antibiotics: a retrospective analysis. Trop Doct. 2002;32(1):2022.
30. Mathai D, Jones RN, PfallerMA. Epidemiology and frequency of resistance
among pathogens causing urinary tract infections in 1,510 hospitalized
patients: a report from the SENTRY Antimicrobial Surveillance Program
(North America). Diagn Microbiol Infect Dis. 2001;40(3):129136.
31. Farooqi BJ, Shareeq F, Rizvi QK, Qureshi HS, Ashfaq MK. Changing pattern
of antimicrobial susceptibility of organisms causing community acquired
urinary tract infections. J Pak Med Assoc. 2000;50(11):369373.
32. Astal ZE. Increasing ciprofloxacin resistance among prevalent urinary tract
bacterial isolates in Gaza Strip, Palestine. J of Biomed an Biotech.
2005;2005(3):238-41.
33. Refdanita, Maksum R, Nurgani A, Endang. Pola kepekaan kuman terhadap
antibiotika di ruang rawat intensif Rumah Sakit Fatmawati Jakarta tahun
2001 2002. Makara, kesehatan 2004;8(2):41-8.
34. Diekema, D. J., B. J. BootsMiller, T. E. Vaugh, R. F. Woolson, J. W.
Yankey, E. J. Ernst, S. D. Flach, M. M. Ward, C. L. J. Franciscus, M. A.
Pfaller, and B. N. Doebbeling. 2004. Antimicrobial resistance trends and
outbreak frequency in United States hospitals. Clin. Infect. Dis. 38:7885.
35. Neuhauser, M. M., R. A. Weinstein, R. Rydman, L. H. Danziger, G. Karam,
and J. P. Quinn. 2003. Antibiotic resistance among Gram negative bacilli in
US intensive care units. JAMA 289:885888.

Pola kepekaan ..., Firdaus N., FK UI., 2009

Universitas Indonesia

56

36. Viray, M., D. Linkin, J. N. Maslow, D. D. Stieritz, L. S. Carson, W. B.

Bilker,

and

susceptibilities

E.

Lautenbach.
across

Longitudinal

long-term-care

trends

facilities:

in

antimicrobial

emergence

of

fluoroquinolone resistance. Infect. Cont. Hosp. Epidemiol. 2005. 26:5662.

37. Zhanel, G. G., T. L. Hisanaga, N. M. Laing, et al, and the NAUTICA Group.
Antibiotic resistance in outpatient urinary isolates: final results from the
North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Int. J. Antimicrob. Agents. 2005. 26:380388.
38. Goettsch, W., W. van Pelt, N. Nagelkerke, M. et al. Increasing resistance to
fluoroquinolones in Escherichia coli from urinary tract infections in The
Netherlands. J. Antimicrob. Chemother. 2000. 46:223228.
39. Alos JI, Serrano MG, Gomez-Garces JL, Perianes J: Antibiotic resistance of
Escherichia coli from community acquired urinary tract infections in relation
to demographic and clinical data. Clin Microbiol Infect. 2005, 11:199-203.
40. Hames L, Rice CE: Antimicrobial Resistance of Urinary Tract Isolates in
acute uncomplicated cystitis among college aged women: Choosing a first
line therapy. J Am Coll Health 2007, 56:153-156.
41.

Pola kepekaan ..., Firdaus N., FK UI., 2009

Universitas Indonesia